(1)
Tosi, M.; Catteruccia, M.; Cherchi, C.; Mizzoni, I.; D’Amico, A. Switching Therapies: Safety Profile of Onasemnogene Abeparvovec-Xioi in a SMA1 Patient Previously Treated With Risdiplam. Acta Myol 2022, 41, 117-120.